Number of the records: 1  

Synergistic effect of HPMA copolymer-bound doxorubicin and dexamethasone in vivo on mouse lymphomas

  1. 1.
    SYSNO ASEP0359969
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSynergistic effect of HPMA copolymer-bound doxorubicin and dexamethasone in vivo on mouse lymphomas
    Author(s) Kostková, Hana (UMCH-V) RID
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Říhová, Blanka (MBU-M) RID
    Ulbrich, Karel (UMCH-V) RID
    Source TitleJournal of Bioactive and Compatible Polymers. - : Sage - ISSN 0883-9115
    Roč. 26, č. 3 (2011), s. 270-286
    Number of pages17 s.
    Languageeng - English
    CountryGB - United Kingdom
    KeywordsHPMA copolymer ; doxorubicin ; dexamethasone
    Subject RIVCD - Macromolecular Chemistry
    R&D ProjectsIAAX00500803 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    IAA400500806 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    1M0505 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z40500505 - UMCH-V (2005-2011)
    AV0Z50200510 - MBU-M (2005-2011)
    UT WOS000290949300004
    DOI10.1177/0883911511406326
    AnnotationN-(2-Hydroxypropyl)methacrylamide copolymer—drug conjugates bearing the antiinflammatory and anti-proliferative drug dexamethasone (DEX) and the anti-cancer drug doxorubicin (DOX) bound to either the polymer carrier separately or in combination, were synthesized. Both the in vitro and in vivo anti-cancer activity on mouse B-cell (38C13) and T-cell (EL4) lymphoma was studied. The conjugates were fairly stable in model buffers at pH 7.4, simulating blood pH, and the drug was released by chemical hydrolysis at pH values based on the endosomal and lysosomal environments in the target cells (pH 5—6).Contrary to the treatment with either single drug conjugate, where no significant long-term survival was observed, a synergistic effect of the two drugs was manifested in vivo. Treatment of mice bearing B-cell lymphoma 38C13 formulated as a mixture of both single drug-containing conjugates or a as a conjugate with both drugs in combination gave long-term survivors.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.